# Memorial Sloan-Kettering Cancer Center

- Location (FDA's records): New York, NY
- FDA decisions: 1 (2017–2017): 1 De Novo grant
- Product codes: PZM (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 5 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Personal Genome Diagnostics, Inc.: 1 (https://510kreport.com/company/personal-genome-diagnostics)
- Tempus AI, Inc.: 1 (https://510kreport.com/company/tempus-ai)
- Act Genomics: 1 (https://510kreport.com/company/act-genomics)
- Nanthealth, Inc.: 1 (https://510kreport.com/company/nanthealth)
- Datar Cancer Genetics Private Limited: 1 (https://510kreport.com/company/datar-cancer-genetics-private)

## Its most-cited devices
- DEN170058: MSK-IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets):a Hybridization-Capture Based Next Generation Sequencing Assay (2017), cited by 5

## Recent decisions
- DEN170058: MSK-IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets):a Hybridization-Capture Based Next Generation Sequencing Assay (Nov 15, 2017)

Source page: https://510kreport.com/company/memorial-sloan-kettering-cancer-center